Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

AmBisome approved for marketing in Spain

April 12, 1996

Mentax approvable for athlete's foot

April 12, 1996

New antifungals isolated from actinomycetes at Schering-Plough

April 12, 1996

L-742728 selected by Merck & Co. for further evaluation

April 12, 1996

Virend entering phase III

April 5, 1996

Nabi foresees phase I/II trials on CMV NeutraGAM

April 5, 1996

Lidakol formulations receive patent protection

April 5, 1996

BILD-1351 for HSV infection

April 5, 1996

BMS discloses novel cephalosporins

April 5, 1996

MBI-10 antibiotics effective against resistant staphylococci

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...